
Similar Posts

Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.

Analyst names China internet stocks that will benefit from a more stable regulatory environment in 2022
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email A few Chinese internet companies are expected to grow their market share as the regulatory environment stabilizes and government sets to stimulate the economy, says James Lee from Mizuho Securities. 02:22 Sun, Feb 6 202210:58 PM EST

Tax policy on the ballot: Where each 2024 presidential candidate stands on taxes
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Erica York, Tax Foundation senior economist, joins ‘Squawk Box’ to discuss the foundation’s tax policy tracker, where each 2024 presidential candidate stands on taxes, and more.

Citi’s restructuring will work this time, says Wells Fargo’s Mike Mayo
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell Mike Mayo, Wells Fargo bank analyst, joins ‘Closing Bell’ to discuss Citi’s Q4 warning, his bank earning predictions, and more. 05:16 7 minutes ago

Can I Afford It? $130,000 Ferrari
Forty-eight year old Max wants to know if he can afford to buy his dream car.

A point-of-sale system like Square on steroids
A New York City cowboy boot store may sell classic styles, but it’s been improving its sales by using technology and analytics on the Bindo POS iPad app.